Celgene

This study tested a new oral drug, CC-92480, given alone and with a steroid (dexamethasone), for adults with multiple myeloma that has come back and stopped responding to many standard treatments. The main goals were to find a safe dose and see if the drug combination could shrin…

This early-stage trial tested whether combining a personalized immune cell therapy (called bb2121 or ide-cel) with other drugs could help adults with multiple myeloma that had returned or stopped responding to standard treatments. The study aimed to find safe doses and see if the…

This study aimed to evaluate the long-term safety and effectiveness of the oral medication ozanimod for adults with moderate to severe Crohn's disease. It was an extension study for 854 participants who had already completed earlier phases of ozanimod research. The main goals wer…

This study tested whether a daily pill called ozanimod could help people with moderate to severe Crohn's disease stay in remission. It involved about 550 participants who had already responded to initial treatment. The main goal was to see if the pill could keep their symptoms lo…

This study tested whether a daily pill called ozanimod could help control symptoms and reduce gut inflammation in adults with moderate to severe Crohn's disease. It involved 625 participants whose current treatments weren't working well enough. The main goal was to see if the pil…